Figure 3From: Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Mean overall improvements in health-related quality of life (ILC-LQ0-28). Data are presented for the overall population and by age subgroups (intention-to-treat, last observation carried forward). High scores denote high quality of life.Back to article page